Jump to Main Content

Advocacy

Policy News

Submit
Reset

CMS Expands Telehealth Benefits and Waives Penalties for HIPAA Violations During COVID-19 Outbreak

Mar 25
2020

Expanded Telehealth Benefits  On March 17, the Centers for Medicare and Medicaid Services (CMS) expanded telehealth benefits for Medicare beneficiaries during the COVID-19 outbreak to allow individuals to receive a wider range of healthcare serv...

Read more

Access to Care and Drug Pricing: An Update for 2019

Nov 22
2019

The American Society of Hematology (ASH) believes that all individuals should have access to and be able to afford high-quality, clinically appropriate care, including innovative therapeutics. Hematologists treat patients with malignant hematologic d...

Read more

ASH Issues Recommendations to the NCI on CCDI

Aug 23
2019

ASH submitted comments to the National Cancer Institute (NCI) on ways in which improved childhood cancer data sharing could inform hematology-related pediatric research questions, data collection and data analysis tools. ASH&rsquo...

Read more

CAR T-cell Therapy: An Update on Coverage and Reimbursement

Aug 14
2019

ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. ASH members are at the forefront of this therapy, conducting research and providing this potentially curative treatment to patient...

Read more

Court Rules ACA Unconstitutional

Dec 17
2018

On December 14, 2018, a federal judge in Texas ruled that the Affordable Care Act (ACA) is unconstitutional now that Congress has eliminated the individual mandate penalty. The ruling came in response to a lawsuit brought against the federal governme...

Read more

2018 Research and Public Health Funding Advocacy Highlights

Dec 11
2018

During 2018, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CD...

Read more

2018 Physician Payment Advocacy Highlights

Dec 11
2018

2019 Medicare Inpatient Hospital Rule ASH offered comments on the 2019 proposed rule for the Inpatient Prospective Payment System (IPPS). The rule determines payment levels and related provisions for Medicare patients who are admitted to the hospital...

Read more

2018 ASH Advocacy Efforts to Ensure Patient Access to Care

Dec 11
2018

Drug Access High drug prices are a major issue facing patients with hematologic conditions and ASH continues to identify and advocate for ways to ensure access to safe and effective hematologic drugs. Updates on the Society’s major advocacy eff...

Read more

2018 ASH Advocacy Activities

Dec 11
2018

In advocacy, there is strength in numbers, so ASH is continuing to increase its efforts to expand and enhance the Society’s reach. Funding for the National Institutes of Health (NIH), efforts to ensure patient access to drugs, and authorization...

Read more

2018 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

Dec 11
2018

The American Society of Hematology (ASH) is committed to addressing the burden of sickle cell disease (SCD) and is undertaking a multifaceted initiative to improve outcomes for individuals with the disease, both in the United States and globally. ASH...

Read more